tirzepatide for cardiovascular disease Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Tirzepatide and Cardiovascular Health: Protect

The secret to avoiding a crash of the destination spa industry, it turns out, might be embracing their current pharmacological threat as a key part of their programme

Mendelian randomization: genetic anchors for causal inference in epidemiological studies

The gradual dose escalation schedule is specifically designed to minimise these symptoms

It turns out if you have a very large battery you don't need a high C rating, because the C rating is a % of the total capacity

For most neurological conditions, starting earlier probably gives better results, but we still do not know the best time to start GLP-1 receptor agonist therapy